【ChiCTR2000029127】Association of Body Mass Index and diet with Symptomatic Gall Stone Disease: A Case-Control Study
ChiCTR2000029127
结束
/
/
/
2020-01-15
/
/
gall stones
Association of Body Mass Index and diet with Symptomatic Gall Stone Disease: A Case-Control Study
Association of body mass index and diet with symptomatic gall stone disease: a case-control study
this study was conducted to identify the association of gall stone disease with certain dietary intake and BMI in our population as local data is deficient in this regard. moreover, the dietry habits in our population are bit different from the western population.
横断面
其它
N/A
N/A
无
/
396
/
2012-06-23
2017-12-22
/
All female patients above 25 years of age with symptomatic gall stones on upper abdominal ultrasonography as cases and all patients( females) above 25 years of age with no gall stones on upper abdominal ultrasonography (done for any reason) as controls were included in the study；
请登录查看Patient with gall stones having some other clear predisposing cause for gallstone formation other than weight and dietary fat intake (e.g. Stoma, Sudden weight loss etc.).；
请登录查看no sponser was involved
/
no sponser was involved的其他临床试验
巴基斯坦伊斯兰堡shifa tameer-e-millat大学的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04